Efficacy of gene therapy demonstrated in patients suffering from Crigler-Najjar Syndrome Crigler-Najjar syndrome is characterized by hyperbilirubinemia. If it is not treated quickly, the build-up of bilirubin, due to a deficiency in the liver enzyme UGT1A1, can cause significant neurological damage and become fatal. At the current time, the only…..
Quantoom Biosciences is growing in Evry Quantoom Biosciences, a Belgian biotech dedicated to mRNA production and part of the global life science group Univercells, is opening a brand-new facility in Évry-Courcouronnes (France). Following the SynHelix acquisition in 2021, Quantoom already had infrastructures in France, part of the Genopole campus, but…..
Pierre Fabre to commercialize and distribute the first approved allogeneic T-cell immunotherapy in Europe Following transfer of the European Commission marketing authorization from Atara Biotherapeutics, Pierre Fabre is to lead launch and commercialization activities for Ebvallo® (tabelecleucel) in Europe The french group Pierre Fabre and Atara Biotherapeutics, a californian biotech…..
Creation of the Institut Pasteur-UCSF QBI Center of Excellence in Emerging Infectious Diseases Two academic and scientific heavyweights, the Institut Pasteur and UC San Francisco Quantitative Biosciences Institute (UCSF QBI), agree to implement joint actions towards the creation of a center of excellence in emerging infectious diseases with planned operations/locations…..
Longer life due to faulty RNA processing [caption id="" align="aligncenter" width="700"] The roundworm Caenorhabditis elegans is an important model organism in ageing research. The worm in the image is labelled with GFP::RNP-6. Credit: Max Planck Institute for Biology of Ageing[/caption] RNA is an important transmitter of information in our cells…..
Pegcetacoplan treatment shows increased effects over time in geographic atrophy Pegcetacoplan, a targeted C3 therapy designed to regulate excessive activation os the complement cascade, is on track to become the first treatment for geographic atrophy (GA) with a PDFU date of Nov. 26 and EU MAA submission on track by…..
China'BGI Genomics exports its thalassemia detection kits in Azerbaijan Azerbaijan Thalassemia Center will be one of Chinese BGI's pioneer overseas thalassemia projects in a country with a high prevalence rate of this disease. On 6th September 2022, the Azerbaijan Thalassemia Center and BGI Genomics held a virtual signing ceremony to…..
Carroucell has raised €1.5 million Carroucell, a French microcarrier supplier for cell culture in bioreactor, has raised a total of €1.5 million. The funding includes the closing of a Series A financing, led by the Novalis Biotech Acceleration fund and with participation of Crédit Agricole des Savoie (CADS), as well…..
KU Leuven spin-off AstriVax raises € 30 million to build vaccine platform AstriVax will draw on technology developed at the KU Leuven Rega Institute (Belgium) to develop novel vaccines that are easy to produce, have reduced cold chain requirements, and offer broad and long-lasting protection against various pathogens. Closing on…..
Demonstration of a potent, universal coronavirus monoclonal antibody therapy for all COVID-19 variant Researchers at University of Alabama at Birmingham (UAB), Texas Biomedical Research Institute and Aridis Pharmaceuticals discovered a neutralizing monoclonal antibody that potentially acts as a potent universal coronavirus therapy against SARS-CoV-2 and all its variants of concern,…..
- Page Précédente
- 1
- 2
- 3
- 4
...
- 21
- Page Suivante
